Overview

• CVS reported adjusted second-quarter earnings of $1.81 per share, beating the $1.46 average analyst forecast.
• The company raised its full-year 2025 earnings outlook to a range of $6.30 to $6.40 per share, up from $6.00 to $6.20.
• Revenue climbed 8 percent year over year to $98.9 billion, surpassing analysts’ $94.51 billion estimate.
• Aetna’s medical loss ratio improved to 89.9 percent in the quarter, stronger than the 91.16 percent expected.
• CVS plans to close 250 pharmacies, cut back its government-sponsored insurance offerings and reprice half of its Medicare Advantage plans for 2026.